These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23055346)

  • 1. Maternal serum second trimester screening for chromosomal disorders and neural tube defects in a government hospital of North India.
    Kaur G; Srivastav J; Kaur A; Huria A; Goel P; Kaur R; Kataria S; Chavan BS; Kochhar S; Aggarwal P; Kaur N; Panigrahi I; Chawla P
    Prenat Diagn; 2012 Dec; 32(12):1192-6. PubMed ID: 23055346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Maternal serum screening for Down syndrome and neural tube defects].
    van Rijn M; Christiaens GC; van der Schouw YT; Hagenaars AM; de Pater JM; Visser GH
    Ned Tijdschr Geneeskd; 1998 Feb; 142(8):409-15. PubMed ID: 9562776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major fetal abnormalities associated with positive screening tests for Smith-Lemli-Opitz syndrome (SLOS).
    Craig WY; Haddow JE; Palomaki GE; Roberson M
    Prenat Diagn; 2007 May; 27(5):409-14. PubMed ID: 17286308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal genetic screening for Down syndrome and open neural tube defects using maternal serum markers in Thai pregnant women.
    Wasant P; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():244-8. PubMed ID: 15906746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study].
    Qi QW; Jiang YL; Liu JT; Bian XM; Li Y; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Cai Y
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):737-41. PubMed ID: 19087538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Maternal serum screening for congenital abnormalities and Down syndrome in Sønderjylland County. Eight years of experience].
    Christiansen M; Petersen PL; Permin M; Larsen LA; Nørgaard-Pedersen B
    Ugeskr Laeger; 1999 Dec; 161(50):6928-34. PubMed ID: 10643380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contingent triple-screening for Down syndrome in the second trimester: a feasibility study in Mainland Chinese population.
    Xie Z; Lu S; Li H
    Prenat Diagn; 2010 Jan; 30(1):74-6. PubMed ID: 19967750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of prenatal serum biomarker screening for neural tube defects in second trimester pregnant women: a meta-analysis.
    Wang ZP; Li H; Hao LZ; Zhao ZT
    Prenat Diagn; 2009 Oct; 29(10):960-5. PubMed ID: 19609892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum screening of Palestinian women in the West Bank.
    Husseini A; Akkawi M
    East Mediterr Health J; 2005 Jul; 11(4):824-7. PubMed ID: 16700399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MULTISCAN--a Scandinavian multicenter second trimester obstetric ultrasound and serum screening study.
    Jørgensen FS; Valentin L; Salvesen KA; Jørgensen C; Jensen FR; Bang J; Eik-Nes SH; Madsen M; Marsal K; Persson PH; Philip J; Bogstad JW; Nørgaard-Pedersen B
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):501-10. PubMed ID: 10376859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening.
    Jou HJ; Kuo YS; Hsu JJ; Shyu MK; Hsieh TT; Hsieh FJ
    Prenat Diagn; 2005 Aug; 25(8):665-70. PubMed ID: 16049991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prenatal serum screening of aneuploidy and of neural tube defects in the second trimester of pregnancy among the population of Luxembourg. Evaluation of risk by the triple test (AFP+THCG+UE3)].
    Thix J
    Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(1):25-9. PubMed ID: 9303823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential pathways of testing after first-trimester screening for trisomy 21.
    Platt LD; Greene N; Johnson A; Zachary J; Thom E; Krantz D; Simpson JL; Silver RK; Snijders RJ; Goetzl L; Pergament E; Filkins K; Mahoney MJ; Hogge WA; Wilson RD; Mohide P; Hershey D; MacGregor S; Bahado-Singh R; Jackson LG; Wapner R;
    Obstet Gynecol; 2004 Oct; 104(4):661-6. PubMed ID: 15458882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fifteen years of triple tests in The Netherlands; the life cycle of a screening test.
    Wortelboer EJ; Koster MP; Stoutenbeek P; Loeber JG; Visser GH; Schielen PC
    Prenat Diagn; 2008 Oct; 28(10):950-5. PubMed ID: 18821712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.